DIEBOLD NIXDORF INC (DBD) Stock Analyst Ratings
NYSE:DBD - New York Stock Exchange, Inc. - US2536512021 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to DBD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 63.75. This target is 38.89% above the current price.
DBD was analyzed by 6 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DBD.
In the previous month the buy percentage consensus was at a similar level.
DBD was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-12 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-08-09 | DA Davidson | Maintains | Buy -> Buy |
| 2024-08-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-07-25 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-05-03 | Wedbush | Upgrade | Neutral -> Outperform |
| 2024-04-25 | Wedbush | Reiterate | Neutral -> Neutral |
| 2024-02-15 | Wedbush | Maintains | Neutral -> Neutral |
| 2024-02-12 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-11-10 | DA Davidson | Upgrade | Neutral -> Buy |
| 2023-11-10 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-10-30 | Wedbush | Reiterate | Neutral -> Neutral |
| 2023-08-18 | Wedbush | Maintains | Neutral -> Neutral |
| 2023-08-15 | DA Davidson | Reiterate | Neutral -> Neutral |
| 2023-05-04 | Wedbush | Downgrade | Outperform -> Neutral |
| 2023-03-17 | Wedbush | Reiterate | Outperform |
| 2022-10-24 | DA Davidson | Downgrade | Buy -> Neutral |
| 2022-08-12 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2022-07-08 | Wedbush | Upgrade | Neutral -> Outperform |
| 2021-06-21 | Wedbush | Initiate | Neutral |